Technology | April 29, 2009

FDA Clears Patient Positioning System for Improved Proton Therapy


April 29, 2009 – The FDA cleared of a new generation of patient positioning system (PPS) developed by Ion Beam Applications S.A. (IBA) and ProCure Treatment Centers Inc. (ProCure), which is designed to improve proton therapy.

The basic configuration of the robotic PPS is a Selective Compliant Assembly Robot Arm (SCARA). It combines commercially available robotic sub-systems, which makes it cost-effective and easy to maintain, with custom designed arms to allow for the specific needs of patient positioning in proton therapy. A unique dual coupler system is attached at the end of the wrist of the robot arm that is used to attach different devices to the PPS, such as a patient table or chair, or a test phantom. The device employs reportedly safe robotic technology that meets the standards of the Robotics Industry Association (RIA).

Some specific design elements of the PPS compared to earlier generations include:

- An increase of the clinically usable area of the proton therapy treatment room. This larger work envelope also makes it suitable for image-guided proton therapy in combination with 3D imaging capability in the treatment room.

- Optimized movement speeds designed for safe and precise motion of the PPS. The range of speed and motion with the pitch-and-roll axes of the robot is restricted to reduce the sensation of movement when the patient is on the table.

- The ergonomics are said to be better, as there are no moving parts in the floor system that supports the device, which allows greater accessibility to the treatment area for patients and therapists

The new PPS is part of ProCure’s strategy to make proton therapy better and more accessible. This includes making the therapy more cost effective and creating a platform that will allow easy integration of future advanced image-guided proton treatments.

The first clinical installation will be at the ProCure Proton Therapy Center in Oklahoma City, scheduled to open this summer.

For more information: www.procure.com

Related Content

Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
MedStar Georgetown Conducts World's First Hyperscan Proton Therapy Treatment
News | Proton Therapy | April 27, 2018
For the first time, cancer patients in the Washington, D.C. metropolitan region have access to proton therapy, now...
First Patient Treated on Mevion's S250i Proton Therapy System
News | Proton Therapy | April 05, 2018
Mevion Medical Systems announced the treatment of the first patient in the world on the Mevion S250i Proton Therapy...
MEDraysintell released a report in January revising its projection for the number of proton therapy centers worldwide by 2030 down from 1,200 to 900. The company said that more than 50 proton therapy treatment rooms would need to be opened every year from 2018 to 2030 to hit the original projection of 1,200.

MEDraysintell released a report in January revising its projection for the number of proton therapy centers worldwide by 2030 down from 1,200 to 900. The company said that more than 50 proton therapy treatment rooms would need to be opened every year from 2018 to 2030 to hit the original projection of 1,200.

Feature | Proton Therapy | March 06, 2018 | By Jeff Zagoudis
Proton therapy has experienced major growth in the last decade, but that growth seems to have slowed slightly in recent...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
RayStation Selected for India’s First Proton Center
News | Proton Therapy | February 01, 2018
February 1, 2018 – Apollo Hospitals, Asia´s foremost integrated healthcare provider, has selected RayStation for a ne
IBA Announces First Patient Treated with Proteus PLUS in The Netherlands
News | Proton Therapy | January 25, 2018
January 25, 2018 –  IBA (Ion Beam Applications SA) has announced that the University Medical Center Groningen (UMCG)
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
Overlay Init